SNE-101 / S&E bio - LARVOL DELTA

Multimodal Antiatherosclerotic Effects of Clinical-Grade Mesenchymal Stem Cell-Derived Extracellular Vesicles. (PubMed, Stroke) - "By enhancing cholesterol efflux, suppressing PCSK9 and Lp(a), and reducing systemic inflammation, SNE-101 addresses critical cardiovascular risks. This provides strong mechanistic guidance for its application in ongoing clinical trials for acute ischemic stroke."

Journal • Atherosclerosis • Cardiovascular • Dyslipidemia • Inflammation • Ischemic stroke • ABCA1 • APOE • PPARG